JAMES R III GAVIN

CIK 1220966 · President and CEO · last filed 2020-09-15

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$909.9K

Companies

3

Total Filings

106

Lifetime Open-Market Net

-$5.33M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BAX Director 43,618 $20.86 $909.9K -$5.10M 68 2020-09-15
Baxalta Inc (BXLT) Delisted Director 30,747 -$226.2K 4 2016-05-12
AMYLIN PHARMACEUTICALS INC (AMLN) Delisted Director 4,580 -$10.0K 29 2012-05-24

Recent Filings · Page 3 of 11

106 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-05-18 BAX Grant (A) $0 EDGAR
2016-05-12 Baxalta Inc (BXLT) Delisted Grant (A) +4,500 $0 EDGAR
2016-05-05 BAX Grant (A) +2,590 $0 EDGAR
2016-03-28 Baxalta Inc (BXLT) Delisted Mixed -$124.5K EDGAR
2016-03-15 BAX Mixed -$109.7K EDGAR
2016-01-28 BAX Grant (A) $0 EDGAR
2015-10-21 BAX Grant (A) $0 EDGAR
2015-08-07 Baxalta Inc (BXLT) Delisted Grant (A) $0 EDGAR
2015-08-05 BAX Grant (A) $0 EDGAR
2015-07-06 Baxalta Inc (BXLT) Delisted Mixed +26,205 $0 EDGAR
Showing 2130 of 106
Page 3 of 11
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.